Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports on using bevacizumab in combination with chemotherapy for metastatic colorectal cancer in a Phase 2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hopital Jean Minjoz | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN